Immunovant (IMVT) PT Lowered to $24 at Truist Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/4/2026
- Wall Street ends sharply higher as Waller remarks ease rate hike fears
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Raymond James Downgrades Immunovant (IMVT) to Market Perform
June 1, 2021 3:31 PM EDTRaymond James analyst Danielle Brill downgraded Immunovant (NASDAQ: IMVT) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Immunovant click here. For more ratings news on Immunovant click here.
Shares of Immunovant closed at $15.16 yesterday.
... MoreGuggenheim Downgrades Immunovant (IMVT) to Neutral
June 1, 2021 1:22 PM EDTGuggenheim analyst Yatin Suneja downgraded Immunovant (NASDAQ: IMVT) from Buy to Neutral.
For an analyst ratings summary and ratings history on Immunovant click here. For more ratings news on Immunovant click here.
Shares of Immunovant closed at $15.16 yesterday.
... MoreStifel Downgrades Immunovant (IMVT) to Hold
June 1, 2021 10:27 AM EDTStifel analyst Derek C. Archila downgraded Immunovant (NASDAQ: IMVT) from Buy to Hold with a price target of $9.00 (from $28.00).
The analyst commented, "This morning, IMVT provided an update indicating that IMVT-1401's LDL increases are due to the on-target reductions of albumin that... More
